Nerve & Muscle Center of Texas Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT02068027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Nerve and Muscule Center of Texas

Active Ingredients

Drugs in Phase 2 Trials (1)

clonidine (catapres) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Neuropathies (Phase 2)

Pain (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1